Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell

• Publication date

  2007-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CELL.2006.10.047PMID 17218256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Tyrosine Kinase Syk Regulates TPL2 Activation Signals*

  2006cited by this paper
• Tumor Necrosis Factor-α Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression*

  2006cited by this paper
• 3BP2 Deficiency Impairs the Response of B Cells, but Not T Cells, to Antigen Receptor Ligation

  2006cited by this paper
• Colony-stimulating factor-1 in immunity and inflammation.

  2006cited by this paper
• Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.

  2005cited by this paper
• Osteoclast precursors, RANKL/RANK, and immunology

  2005cited by this paper
• Role of nuclear factor‐κB in the immune system and bone

  2005cited by this paper
• Coordinating ERK/MAPK signalling through scaffolds and inhibitors

  2005cited by this paper
• αvβ3 and macrophage colony‐stimulating factor: partners in osteoclast biology

  2005cited by this paper
• Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone

  2005cited by this paper
• alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology.

  2005cited by this paper
• Vav3 regulates osteoclast function and bone mass

  2005cited by this paper
• VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice.

  2005cited by this paper
• Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL–RANK signaling system

  2005cited by this paper
• M-CSF mediates TNF-induced inflammatory osteolysis.

  2005influential reference
• Role of nuclear factor-kappaB in the immune system and bone.

  2005cited by this paper
• The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.

  2005influential reference
• Point mutations of 3BP2 identified in human‐inherited disease cherubism result in the loss of function

  2004cited by this paper
• The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase

  2004influential reference
• Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

  2004influential reference
• Therapeutic strategies for rheumatoid arthritis.

  2004cited by this paper
• The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.

  2004cited by this paper
• Adaptor Protein 3BP2 Is a Potential Ligand of Src Homology 2 and 3 Domains of Lyn Protein-tyrosine Kinase*

  2003cited by this paper
• Therapeutic strategies for rheumatoid arthritis

  2003cited by this paper
• High dose M‐CSF partially rescues the Dap12−/− osteoclast phenotype

  2003cited by this paper
• The Chaperone Protein 14-3-3 Interacts with 3BP2/SH3BP2 and Regulates Its Adapter Function*

  2003influential reference
• Regulation of Signaling in B Cells through the Phosphorylation of Syk on Linker Region Tyrosines

  2002cited by this paper
• Regulation of FcεRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells

  2002cited by this paper
• Points of control in inflammation

  2002cited by this paper
• SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts

  2002cited by this paper
• Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells.

  2002cited by this paper
• Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

  2002influential reference
• Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism

  2001cited by this paper
• Regulation of NK Cell-Mediated Cytotoxicity by the Adaptor Protein 3BP21

  2001cited by this paper
• TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.

  2000cited by this paper
• Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome.

  2000cited by this paper
• TNF-a Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

  2000cited by this paper
• The gene for cherubism maps to chromosome 4p16.

  1999cited by this paper
• The gene for cherubism maps to chromosome 4p16.3.

  1999cited by this paper
• Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation.

  1998influential reference
• Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.

  1996influential reference
• Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk

  1996cited by this paper
• Phospholipase C- (cid:103) 1 Interacts with Conserved Phosphotyrosyl Residues in the Linker Region of Syk and Is a Substrate for Syk

  1996cited by this paper
• Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.

  1994cited by this paper
• Identification of a ten-amino acid proline-rich SH3 binding site.

  1993cited by this paper
• Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages

  1990cited by this paper

• Immune Involvement in the Development and Maintenance of Oral and Craniofacial Bones.

  2026cites this paper
• Autoinflammatory Bone Diseases

  2025cites this paper
• Endogenous Osteocyte-Osteoclast Signaling Enables Growth Factor-Free Bone Remodeling, Drug Response, and Cancer Invasion in a Nanoscale Calcified Bone-on-a-Chip Model

  2025cites this paper
• Comparative analysis of osteoclast function in symptomatic and asymptomatic individuals with cherubism-causing SH3BP2 mutation

  2025cites this paper
• The bone phenotype associated with cherubism is independent of Caspase-1-dependent inflammasome activation in the mouse

  2025influential citation
• PARylation-mediated post-transcriptional modifications in cancer immunity and immunotherapy

  2025cites this paper
• Chiral Supramolecular Hydrogels Regulating Both Osteoblastogenesis and Osteoclastogenesis

  2025cites this paper
• Successful treatment of adult cherubism with a 60 mg denosumab 6-monthly regimen

  2024cites this paper
• Loss of TBC1D2B causes a progressive neurological disorder with gingival overgrowth

  2024cites this paper
• Loss-of-function OGFRL1 variants identified in autosomal recessive cherubism families

  2024influential citation
• Emerging Role of SH3BP2 as Regulator of Immune and Nonimmune Cells in Nephrotic Syndrome

  2024influential citation
• Cell fusion dynamics: mechanisms of multinucleation in osteoclasts and macrophages

  2024cites this paper
• Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients

  2023cites this paper
• Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single‐Center Cohort Study

  2023cites this paper
• E3-ubiquitin ligases and recent progress in osteoimmunology

  2023cites this paper
• Pharmacological management of cherubism: A systematic review

  2023cites this paper
• Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome

  2023cites this paper
• PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism.

  2023cites this paper
• Tankyrase represses autoinflammation through the attenuation of TLR2 signaling

  2022cites this paper
• Roles of osteoclasts in alveolar bone remodeling

  2022cites this paper
• OC_Finder: Osteoclast Segmentation, Counting, and Classification Using Watershed and Deep Learning

  2022cites this paper
• Overexpression of DEL-1 Downregulates SH3BP2 Expression and Inhibits Porphyromonas gingivalis-induced Gingival Inflammation In Vivo and In Vitro

  2022cites this paper
• Osteoclasts, Master Sculptors of Bone.

  2022cites this paper
• Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induce cytokine expression and NF-κB activation.

  2022cites this paper
• SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis

  2021cites this paper
• The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases

  2021cites this paper
• Cherubism treated with intranasal calcitonin: A case report and literature review

  2021cites this paper
• Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.

  2021influential citation
• OC_Finder: A deep learning-based software for osteoclast segmentation, counting, and classification

  2021cites this paper
• LIM Kinases in Osteosarcoma Development

  2021cites this paper
• Multiple versus Solitary Giant Cell Lesions of the Jaw: Similar or Distinct Entities?

  2021cites this paper
• Tlr2/4‐Mediated Hyperinflammation Promotes Cherubism‐Like Jawbone Expansion in Sh3bp2 (P416R) Knockin Mice

  2021cites this paper
• Role of osteoclasts in oral homeostasis and jawbone diseases.

  2020cites this paper
• Cherubism: a systematic literature review of clinical and molecular aspects.

  2020cites this paper
• Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism

  2020cites this paper
• Cherubism as a systemic skeletal disease: evidence from an aggressive case

  2020cites this paper
• Unusual Characteristics and Variable Expressivity in a Brazilian Family with Cherubism

  2020cites this paper
• SH3BP2 Deficiency Ameliorates Murine Systemic Lupus Erythematosus

  2020cites this paper
• Osteoclasts in Skeletal Diseases

  2020cites this paper
• Late reactivation of cherubism in an adult further to local inflammation.

  2020cites this paper
• Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism.

  2020cites this paper
• Alveolar Bone Protection by Targeting the SH3BP2‐SYK Axis in Osteoclasts

  2020cites this paper
• Investigating global gene expression changes in a murine model of cherubism.

  2020influential citation
• SH3BP2 Gene

  2020cites this paper
• Mycobacterial and Plasmodium ovale-associated destruction of the jaw bones.

  2020cites this paper
• SH3BP2 De ciency Ameliorates Murine Systemic Lupus Erythematosus

  2020cites this paper
• Microbe‐Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice

  2020cites this paper
• Heterogeneity and Actin Cytoskeleton in Osteoclast and Macrophage Multinucleation

  2020cites this paper
• Cherubism

  2020cites this paper
• Bone dynamics and inflammation: lessons from rare diseases

  2020cites this paper
• A report of two atypical genetic cases of cherubism: Reduced penetrance and sporadic occurrence

  2020cites this paper
• RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice

  2020cites this paper
• Adjuvant Alendronic Acid in the Management of Severe Cherubism: A Case Report and Literature Review.

  2020cites this paper
• LDC000067 suppresses RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced osteolysis in vivo.

  2019cites this paper
• Role of APD-Ribosylation in Bone Health and Disease

  2019cites this paper
• Osteoimmunology.

  2019cites this paper
• Regional Lymph Node Enlargement in Clinically Severe Cherubism

  2019cites this paper
• Osteoimmunology: evolving concepts in bone–immune interactions in health and disease

  2019cites this paper
• Genetic Disruption of Anoctamin 5 in Mice Replicates Human Gnathodiaphyseal Dysplasia (GDD)

  2019cites this paper
• Cranial Developmental Disorder Cherubism

  2019cites this paper
• Genetic Causes of Inflammatory Bone Disease

  2019cites this paper
• Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2

  2019influential citation
• Clinicoradiologic follow up of cherubism with aggressive characteristics: a series of 3 cases.

  2019cites this paper
• Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice

  2019cites this paper
• Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.

  2018cites this paper
• Second‐Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model

  2018influential citation
• Rapid degradation of progressive ankylosis protein (ANKH) in craniometaphyseal dysplasia

  2018cites this paper
• Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation

  2018cites this paper
• The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders

  2018cites this paper
• Cherubism Mice Also Deficient in c‐Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts

  2018cites this paper
• Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.

  2018cites this paper
• Dual‐specificity tyrosine phosphorylation‐regulated kinase 2 regulates osteoclast fusion in a cell heterotypic manner

  2018cites this paper
• ANGPTL2 deletion inhibits osteoclast generation by modulating NF-κB/MAPKs/Cyclin pathways.

  2018cites this paper
• Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations

  2018cites this paper
• Bone involvement in monogenic autoinflammatory syndromes

  2018cites this paper
• Timed Regulation of 3BP2 Induction Is Critical for Sustaining CD8+ T Cell Expansion and Differentiation

  2018cites this paper
• High-dose PMA with RANKL and MCSF induces THP‑1 cell differentiation into human functional osteoclasts in vitro.

  2017influential citation
• Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells

  2017cites this paper
• Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.

  2017cites this paper
• RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146

  2017influential citation
• Craniofacial and Dental Features in Six Children With Cherubism

  2017cites this paper
• Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

  2017cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Chapter 48 – Autoinflammatory Bone Disorders

  2016cites this paper
• Defining a new aggressiveness classification and using NFATc1 localization as a prognostic factor in cherubism.

  2016cites this paper
• Modeling craniofacial and skeletal congenital birth defects to advance therapies.

  2016cites this paper
• Evidence to support the hypothesis of tuberculosis as a cause of extreme osteonecrosis and osteomyelitis of the mandible in a West African population.

  2016cites this paper
• Defining a new aggressiveness classification and using NFATc 1 localization as a prognostic factor in cherubism Running title : NFATc 1 localization : a prognosis factor for cherubism

  2016influential citation
• Molecular Genetics of Cherubism

  2016cites this paper
• Chérubisme : présentation d’un cas clinique suivi pendant 10 ans et revue de littérature

  2016cites this paper
• Dermatology facing autoinflammatory syndrome.

  2015cites this paper
• Neutrophilic dermatoses and autoinflammatory diseases with skin involvement—innate immune disorders

  2015cites this paper
• Late Reactivation of Cherubism in a Patient With New-Onset Polycystic Ovary Syndrome.

  2015cites this paper
• Une mutation hétérozygote de SH3BP2 amplifie la réponse inflammatoire à l’infection des macrophages dans un modèle de chérubisme chez la souris

  2015cites this paper
• Identification of a point mutation in the SH3BP2 gene in cherubism

  2015cites this paper
• Cherubizm u 9-letniej dziewczynki – opis przypadku i systematyczny przegląd piśmiennictwa

  2015cites this paper
• Loss of SH 3 Domain – Binding Protein 2 Function Suppresses Bone Destruction in Tumor Necrosis Factor – Driven and Collagen-Induced Arthritis in Mice

  2015cites this paper
• Cherubism: Case report and review of literature

  2015cites this paper
• Loss of SH3 Domain–Binding Protein 2 Function Suppresses Bone Destruction in Tumor Necrosis Factor–Driven and Collagen‐Induced Arthritis in Mice

  2015cites this paper
• The Calcineurin Inhibitor Tacrolimus as a New Therapy in Severe Cherubism

  2015influential citation